Morgan L. McLemore, MD
-
RoleHematology Oncology
-
Specialty
-
Research Program
-
Practicing Since2001

Rating: 4.7 out of 5 (142 ratings)
Title/Journal | Authors | Publication Date |
---|---|---|
The Mortality of Adults With Sickle Cell Disease at a Comprehensive Sickle Cell Center. European journal of haematology |
JA Afranie-Sakyi, E Randall, R Fasano, ML McLemore, F El Rassi | 04/01/2025 |
Langerhans Cell Histiocytosis With Hypothalamic-pituitary and Bone Involvement: A Report of 2 Cases. JCEM case reports |
EA Giraldi, JW Allen, ML McLemore, AG Ioachimescu | 03/01/2025 |
Concerns With Statistical Analysis of 2016 CDC Opioid Guideline and Sickle Cell Outcomes. JAMA internal medicine |
AP Patel, M McLemore, VA Sheehan | 09/01/2024 |
AJPM focus |
BK Attell, PM Barrett, BS Pace, ML McLemore, BT McGee, R Oshe, AM DiGirolamo, LL Cohen, AB Snyder | 02/01/2024 |
Adult-onset Langerhans cell histiocytosis of bone: A case series highlighting a rare entity. Annals of diagnostic pathology |
T Javadi, C Hill, ML McLemore, S Oskouei, A Bahrami | 10/01/2023 |
Enhanced IgG immune response to COVID-19 vaccination in patients with sickle cell disease. British journal of haematology |
H Nakahara, N Cheedarla, HP Verkerke, S Cheedarla, SC Wu, JE Hendrickson, A Chang, ML McLemore, F El Rassi, JD Roback, AS Neish, RM Fasano, SR Stowell | 09/01/2023 |
JMIR public health and surveillance |
A Singh, MK Sontag, M Zhou, M Dasgupta, T Crume, M McLemore, N Galadanci, E Randall, N Steiner, AM Brandow, K Koch, JJ Field, K Hassell, AB Snyder, J Kanter | 06/28/2023 |
Expert review of hematology |
K Clarke, YM Shin, MAK Hall, M Moussa, M McLemore, F El Rassi | 02/01/2023 |
Catastrophic Neurological Complications in 2 Patients With Sickle Cell Disease and COVID-19. Journal of investigative medicine high impact case reports |
K Clarke, K Benameur, Z Wiley, YM Shin, M Moussa, F El Rassi, M McLemore | 01/01/2022 |
JCO oncology practice |
AP Jillella, ML Arellano, M Gaddh, AA Langston, LT Heffner, EF Winton, ML McLemore, C Zhang, CR Caprara, KS Simon, SL Bolds, S DeBragga, P Karkhanis, SH Krishnamurthy, J Tongol, MM El Geneidy, A Pati, JM Gerber, MR Grunwald, J Cortes, A Bashey, RK Stuart, VK Kota | 04/01/2021 |
Blood cells, molecules & diseases |
O Niss, RB Lorsbach, M Berger, S Chonat, M McLemore, D Buchbinder, T McCavit, LG Shaffer, J Simpson, JH Schwartz, J Meznarich, M Emberesh, KG Seu, W Zhang, TA Kalfa | 03/01/2021 |
Transfusion |
CL Dean, CL Maier, S Chonat, A Chang, MA Carden, F El Rassi, ML McLemore, SR Stowell, RM Fasano | 05/01/2019 |
Extreme hyperbilirubinemia: An indicator of morbidity and mortality in sickle cell disease. World journal of hepatology |
JP Haydek, C Taborda, R Shah, PA Reshamwala, ML McLemore, FE Rassi, S Chawla | 03/27/2019 |
British journal of haematology |
S Chonat, ML McLemore, ST Bunting, S Nortman, K Zhang, TA Kalfa | 07/01/2018 |
Transfusion-transmitted malaria masquerading as sickle cell crisis with multisystem organ failure. Transfusion |
CL Maier, PJ Gross, CL Dean, S Chonat, A Ip, M McLemore, F El Rassi, SR Stowell, CD Josephson, RM Fasano | 06/01/2018 |
Clinical lymphoma, myeloma & leukemia |
VK Kota, JH Kong, M Arellano, F El Rassi, M Gaddh, LT Heffner, EF Winton, AP Jillella, ML McLemore, HJ Khoury | 12/01/2017 |
A 49-Year-Old Man With Cirrhosis and Pulmonary Fibrosis. Chest |
P Rajaram, B Little, JP Norvell, M McLemore, S Veeraraghavan | 02/01/2016 |
Leukemia & lymphoma |
Z Mitri, MT Siddiqui, F El Rassi, JT Holden, LT Heffner, A Langston, EK Waller, E Winton, M McLemore, L Bernal-Mizrachi, D Jaye, M Arellano, HJ Khoury | 07/01/2014 |
Genistein protects hematopoietic stem cells against G-CSF-induced DNA damage. Cancer prevention research (Philadelphia, Pa.) |
LR Souza, E Silva, E Calloway, O Kucuk, M Rossi, ML McLemore | 05/01/2014 |
Cancer |
AG Antun, S Gleason, M Arellano, AA Langston, ML McLemore, M Gaddh, F el Rassi, L Bernal-Mizrachi, J Galipeau, LT Heffner, EF Winton, HJ Khoury | 11/01/2013 |
G-CSF activation of AKT is not sufficient to prolong neutrophil survival. Journal of leukocyte biology |
LR Souza, E Silva, E Calloway, C Cabrera, ML McLemore | 06/01/2013 |
Characteristics and outcomes of diffuse large B-cell lymphoma presenting in leukaemic phase. British journal of haematology |
D Muringampurath-John, DL Jaye, CR Flowers, D Saxe, Z Chen, MJ Lechowicz, DD Weisenburger, M Bast, ML Arellano, L Bernal-Mizrachi, LT Heffner, M McLemore, JL Kaufman, EF Winton, S Lonial, JO Armitage, HJ Khoury | 09/01/2012 |
Managing chronic myeloid leukemia: a coordinated team care perspective. Clinical lymphoma, myeloma & leukemia |
S Holloway, K Lord, B Bethelmie-Bryan, MW Shepard, J Neely, M McLemore, SK Reddy, A Montero, WS Jonas, SP Gladney, SL Khanwani, SC Reddy, AK Lahiry, LT Heffner, E Winton, M Arellano, HJ Khoury | 04/01/2012 |
Leukemia & lymphoma |
D Muringampurath-John, CR Flowers, M Toscano, C Zhengjia, JL Kaufman, M Arellano, L Bernal-Mizrachi, LT Heffner, MJ Lechowicz, M McLemore, E Winton, DL Jaye, S Lonial, HJ Khoury | 04/01/2012 |
Cancer |
M Arellano, E Winton, L Pan, L Lima, M Tighiouart, K Bhalla, LT Heffner, J Neely, D Hutcherson, M McLemore, A Langston, HJ Khoury | 01/15/2012 |
Prognostic significance of leukopenia at the time of diagnosis in acute myeloid leukemia. Clinical lymphoma, myeloma & leukemia |
M Arellano, L Bernal-Mizrachi, L Pan, M Tighiouart, L Souza, X Guo, M McLemore, L Lima, S Sunay, LT Heffner, Z Chen, GZ Chen, A Langston, E Winton, HJ Khoury | 10/01/2011 |
Leukemia & lymphoma |
LM Lima, K Sampat, S Assouline, D Saxe, S Nault, M Tighiouart, M McLemore, M Arellano, E Winton, L Bernal-Mizrachi, J Cortes, HJ Khoury | 06/01/2011 |
Cancer |
L Lima, L Bernal-Mizrachi, D Saxe, KP Mann, M Tighiouart, M Arellano, L Heffner, M McLemore, A Langston, E Winton, HJ Khoury | 03/15/2011 |
Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.
4.7 |
| Provider showed concern |
4.7 |
| Provider explained things clearly |
4.7 |
| Provider discussed treatment options |
4.7 |
| Provider included you in decisions |
4.7 |
| Likelihood of recommending this provider |
|
04/27/2025 |
Bad; provider ran blood tests already performed which is an extra expense on my part meaning he pays no care to look at my records prior to being seen. |
|
10/18/2024 |
Dr. Mclemore was very thorough, looking at my chart, taking blood (and getting results), before he talked with me. |
|
08/11/2024 |
The physician and staff were very professional and caring. |
|
08/09/2024 |
The Doctor spent time with me and is always very good |
|
07/26/2024 |
He answered my questions. |
|
05/24/2024 |
He was the most knowledgeable doctor I have seen in terms of my disease. |
|
05/08/2024 |
Very good |
|
03/27/2024 |
Most definitely |
|
02/07/2024 |
Top notch interaction! |
|
12/01/2023 |
I thought Dr.McLemore wS just wondetful;very frank and to the point,very informative,very encouraging,very kind and understanding. |
|
11/29/2023 |
I would recommend Dr Macklemore to anyone |
|
10/05/2023 |
Most information received was a result of answers to questions. Not clear if doctor understands the terror of the diagnosis. |
|
09/27/2023 |
I'm very comfortable having Dr McLemore care for me. |
|
08/30/2023 |
Dr McLemore is a great doctor. I will follow his advice. |
|
08/09/2023 |
Dr McLemore is excellent and the fellow was superb as well. |
|
08/02/2023 |
Dr McLemore is an outstanding physician. |
|
08/02/2023 |
So glad I came here |
|
07/12/2023 |
My concerns were addressed. |